
Post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) at the Kitengela sub-county hospital, on February 27, 2024. [File, Standard]
Mary Auma chose love with open eyes. At just 19, she married a man living with HIV—armed not with denial, but with determination and daily doses of Pre-Exposure Prophylaxis (PrEP), the pill she believed would shield her from infection. But now, a year later, that shield is cracking.
Since their marriage in early 2024, she has relied on PrEP– a medication taken by HIV-negative individuals before sex to reduce the risk of transmission from an HIV-positive partner.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login